Pascal Laforet Selected Research

Pascal Laforet Research Topics

Disease

11	Glycogen Storage Disease Type II (Pompe's Disease) 01/2023 - 04/2010
5	Muscular Diseases (Myopathy) 01/2020 - 04/2010
3	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2020 - 01/2018
3	Respiratory Insufficiency (Respiratory Failure) 01/2018 - 09/2006
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2018
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2023 - 01/2018
2	Bundle-Branch Block (Fascicular Block) 06/2019 - 01/2018
2	Heart Failure 06/2019 - 11/2017
2	Glycogen Storage Disease Type III (Cori's Disease) 01/2018 - 05/2015
2	Muscle Weakness 01/2018 - 12/2013
2	Muscular Dystrophies (Muscular Dystrophy) 01/2018 - 08/2012
2	Glycogen Storage Disease (Glycogenosis) 10/2017 - 06/2015
2	Cardiomyopathies (Cardiomyopathy) 12/2013 - 09/2006
1	Left Ventricular Dysfunction 01/2023
1	Inclusion Body Myositis 01/2021
1	Renal Insufficiency (Renal Failure) 01/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Cough 01/2021
1	Deglutition Disorders (Dysphagia) 01/2021
1	Oral Ulcer (Mouth Ulcer) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Disease Progression 01/2020
1	Limb-girdle muscular dystrophy type 2A 01/2020
1	Distal Myopathies (Distal Muscular Dystrophy) 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 06/2019
1	Ventricular Tachycardia 06/2019
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 06/2019
1	Myotonic Dystrophy (Dystrophia Myotonica) 11/2018
1	Neuromuscular Manifestations 01/2018
1	Sarcoglycanopathies 01/2018
1	Cardiomegaly (Heart Hypertrophy) 11/2017
1	Myalgia 11/2012
1	Rhabdomyolysis 11/2012
1	Wasting Syndrome (Wasting Disease) 08/2012
1	Glycogen Storage Disease Type V (McArdle's Disease) 12/2011
1	Body Weight (Weight, Body) 04/2010
1	Myotonia 11/2004
1	Paralysis (Palsy) 11/2004
1	Kearns-Sayre Syndrome 08/2004
1	Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia) 08/2004

Drug/Important Bio-Agent (IBA)

9	AcidsIBA 10/2022 - 04/2010
5	EnzymesIBA 10/2022 - 04/2010
5	alpha-Glucosidases (Acid Maltase)IBA 07/2019 - 04/2010
5	GlycogenIBA 12/2017 - 04/2010
4	GlucosidasesIBA 10/2022 - 06/2015
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2012
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 06/2019 - 12/2018
2	Glycogen Debranching Enzyme System (Glycogen Debranching Enzyme)IBA 01/2018 - 05/2015
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2018
2	DystrophinIBA 01/2018 - 08/2012
2	human GAA protein (Myozyme)FDA Link 01/2017 - 04/2010
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	ametantrone (HAQ)IBA 01/2021
1	CalpainIBA 01/2020
1	CalciumIBA 01/2020
1	AnoctaminsIBA 01/2020
1	DysferlinIBA 01/2020
1	Cysteine Proteases (Cysteine Protease)IBA 01/2020
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 06/2019
1	TropomyosinIBA 06/2019
1	Dynamin IIIBA 06/2019
1	CollagenIBA 12/2018
1	Sarcoglycans (beta Sarcoglycan)IBA 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2014
1	AutoantibodiesIBA 05/2014
1	polyglucosanIBA 12/2013
1	Ligases (Synthetase)IBA 12/2013
1	UbiquitinIBA 12/2013
1	N 30IBA 11/2012
1	glucose tetrasaccharideIBA 02/2012
1	Nonsense Codon (Nonsense Mutation)IBA 12/2011
1	DesminIBA 09/2006
1	ChloridesIBA 11/2004
1	Calcium Channels (Calcium Channel)IBA 11/2004
1	SodiumIBA 11/2004
1	Mitochondrial DNA (mtDNA)IBA 08/2004

Therapy/Procedure

5	Artificial Respiration (Mechanical Ventilation) 01/2023 - 11/2017
5	Enzyme Replacement Therapy 10/2022 - 02/2012
2	Therapeutics 10/2022 - 02/2012
1	Aftercare (After-Treatment) 01/2021
1	Gastrostomy 01/2021
1	Organ Transplantation 01/2021